AR and neoplasm: In line with our previous hypothesis, based on 52 paired cases [5], the primary tumors of patients who developed the most aggressive and ADT-resistant metastases were characterized by particularly high cell proliferation and reduced cellular PSA (marker for low AR activity and cellular dedifferentiation) in the tumor cells.